Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3

Andrew Blauvelt; Melinda Gooderham; Neal Bhatia; Richard G. Langley; Shannon Schneider; John Zoidis; Azra Kurbasic; April Armstrong; Jonathan I. Silverberg

doi:10.1007/s13555-022-00805-y

Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3

Andrew Blauvelt, Melinda Gooderham, Neal Bhatia, Richard G. Langley, Shannon Schneider, John Zoidis, Azra Kurbasic, April Armstrong, Jonathan I. Silverberg

Inernational Relations Division

科研成果: 期刊稿件 › 文章 › 同行评审

6 引用（Scopus）

源语言	英语
页（从-至）	2499-2516
页数	18
期刊	Dermatology and Therapy
卷	12
期	11
DOI	https://doi.org/10.1007/s13555-022-00805-y
出版状态	已出版 - 11月 2022

!!!ASJC Scopus Subject Areas

皮肤医学

访问文件

10.1007/s13555-022-00805-y

其它文件与链接

引用此

Blauvelt, A., Gooderham, M., Bhatia, N., Langley, R. G., Schneider, S., Zoidis, J., Kurbasic, A., Armstrong, A., & Silverberg, J. I. (2022). Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3. Dermatology and Therapy, 12(11), 2499-2516. https://doi.org/10.1007/s13555-022-00805-y

Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3. / Blauvelt, Andrew; Gooderham, Melinda; Bhatia, Neal 等.
在: Dermatology and Therapy, 卷 12, 号码 11, 11.2022, 页码 2499-2516.

科研成果: 期刊稿件 › 文章 › 同行评审

Blauvelt, A, Gooderham, M, Bhatia, N, Langley, RG, Schneider, S, Zoidis, J, Kurbasic, A, Armstrong, A & Silverberg, JI 2022, 'Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3', Dermatology and Therapy, 卷 12, 号码 11, 页码 2499-2516. https://doi.org/10.1007/s13555-022-00805-y

@article{2fd62075540343de937747c2c1c03df8,

title = "Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3",

keywords = "Atopic dermatitis, Geographic region, North America, Patients, Tralokinumab",

author = "Andrew Blauvelt and Melinda Gooderham and Neal Bhatia and Langley, {Richard G.} and Shannon Schneider and John Zoidis and Azra Kurbasic and April Armstrong and Silverberg, {Jonathan I.}",

note = "Publisher Copyright: {\textcopyright} 2022, The Author(s).",

year = "2022",

month = nov,

doi = "10.1007/s13555-022-00805-y",

language = "English",

volume = "12",

pages = "2499--2516",

journal = "Dermatology and Therapy",

issn = "2193-8210",

publisher = "Springer Verlag",

number = "11",

}

TY - JOUR

T1 - Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis

T2 - A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3

AU - Blauvelt, Andrew

AU - Gooderham, Melinda

AU - Bhatia, Neal

AU - Langley, Richard G.

AU - Schneider, Shannon

AU - Zoidis, John

AU - Kurbasic, Azra

AU - Armstrong, April

AU - Silverberg, Jonathan I.

PY - 2022/11

Y1 - 2022/11

KW - Atopic dermatitis

KW - Geographic region

KW - North America

KW - Patients

KW - Tralokinumab

UR - http://www.scopus.com/inward/record.url?scp=85138867134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138867134&partnerID=8YFLogxK

U2 - 10.1007/s13555-022-00805-y

DO - 10.1007/s13555-022-00805-y

M3 - Article

AN - SCOPUS:85138867134

SN - 2193-8210

VL - 12

SP - 2499

EP - 2516

JO - Dermatology and Therapy

JF - Dermatology and Therapy

IS - 11

ER -

Tralokinumab Efficacy and Safety, with or without Topical Corticosteroids, in North American Adults with Moderate-to-Severe Atopic Dermatitis: A Subanalysis of Phase 3 Trials ECZTRA 1, 2, and 3

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此